AUD 0.08
(7.79%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 | 26.89 Million AUD | -11.23% |
2023 | 30.29 Million AUD | -3.13% |
2022 | 31.27 Million AUD | -30.0% |
2021 | 44.68 Million AUD | 32.58% |
2020 | 33.7 Million AUD | 241.41% |
2019 | 9.87 Million AUD | -32.64% |
2018 | 14.65 Million AUD | -42.99% |
2017 | 25.7 Million AUD | 5.95% |
2016 | 24.26 Million AUD | -22.05% |
2015 | 31.12 Million AUD | 53655.38% |
2014 | 57.9 Thousand AUD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 21.57 Million AUD | 0.0% |
2024 Q4 | 26.89 Million AUD | 0.0% |
2024 FY | 26.89 Million AUD | -11.23% |
2023 FY | 30.29 Million AUD | -3.13% |
2023 Q4 | 30.29 Million AUD | 0.0% |
2023 Q2 | 34.36 Million AUD | 0.0% |
2022 Q4 | 31.27 Million AUD | 0.0% |
2022 FY | 31.27 Million AUD | -30.0% |
2022 Q2 | 37.09 Million AUD | 0.0% |
2021 FY | 44.68 Million AUD | 32.58% |
2021 Q4 | 44.68 Million AUD | 0.0% |
2021 Q2 | 28.18 Million AUD | 0.0% |
2020 Q2 | 24.97 Million AUD | 0.0% |
2020 FY | 33.7 Million AUD | 241.41% |
2020 Q4 | 33.7 Million AUD | 0.0% |
2019 Q2 | 13.53 Million AUD | 0.0% |
2019 Q4 | 9.87 Million AUD | 0.0% |
2019 FY | 9.87 Million AUD | -32.64% |
2018 Q2 | 20.04 Million AUD | 0.0% |
2018 FY | 14.65 Million AUD | -42.99% |
2018 Q4 | 14.65 Million AUD | 0.0% |
2017 Q2 | 21.92 Million AUD | 0.0% |
2017 Q4 | 25.7 Million AUD | 0.0% |
2017 FY | 25.7 Million AUD | 5.95% |
2016 Q4 | 24.26 Million AUD | 0.0% |
2016 Q2 | 27.64 Million AUD | 0.0% |
2016 FY | 24.26 Million AUD | -22.05% |
2015 Q4 | 7.83 Million AUD | 0.0% |
2015 FY | 31.12 Million AUD | 53655.38% |
2015 Q3 | 7.83 Million AUD | 0.0% |
2014 FY | 57.9 Thousand AUD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
4DMedical Limited | 120.01 Million AUD | 77.59% |
Adherium Limited | 9.88 Million AUD | -172.02% |
Aroa Biosurgery Limited | 101.82 Million AUD | 73.586% |
Atomo Diagnostics Limited | 11.37 Million AUD | -136.356% |
Anteris Technologies Ltd | 45.7 Million AUD | 41.15% |
Control Bionics Limited | 9.02 Million AUD | -197.929% |
CardieX Limited | 12.64 Million AUD | -112.612% |
Compumedics Limited | 40.35 Million AUD | 33.359% |
Cochlear Limited | 2.74 Billion AUD | 99.02% |
CleanSpace Holdings Limited | 26.05 Million AUD | -3.237% |
Cyclopharm Limited | 45.91 Million AUD | 41.423% |
EMVision Medical Devices Ltd | 23.97 Million AUD | -12.196% |
Nova Eye Medical Limited | 29.88 Million AUD | 9.996% |
HeraMED Limited | 2.95 Million AUD | -811.049% |
Imricor Medical Systems, Inc. | 12.17 Million AUD | -120.885% |
ImpediMed Limited | 46.98 Million AUD | 42.76% |
InhaleRx Limited | 1.57 Million AUD | -1605.579% |
LBT Innovations Limited | 7.93 Million AUD | -239.112% |
Neurotech International Limited | 12.21 Million AUD | -120.209% |
OncoSil Medical Limited | 6.71 Million AUD | -300.318% |
PolyNovo Limited | 109.16 Million AUD | 75.363% |
Respiri Limited | 6.19 Million AUD | -334.427% |
SomnoMed Limited | 69.8 Million AUD | 61.471% |
Universal Biosensors, Inc. | 30.12 Million AUD | 10.708% |
Uscom Limited | 5.13 Million AUD | -423.797% |
Visioneering Technologies, Inc. | 11.2 Million AUD | -140.018% |